Covered recipient · General Payments record
DAVID J CAHN
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$40,235.23
- Reported across 335 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,415.00 | 5 |
| Honoraria | $2,500.00 | 1 |
| Food and Beverage | $2,397.53 | 69 |
| Travel and Lodging | $418.79 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UROGEN PHARMA, INC. | $2,544.28 | 3 |
| Acerta Pharma LLC | $2,423.66 | 3 |
| Telix Pharmaceuticals | $1,891.98 | 3 |
| PFIZER INC. | $1,569.34 | 4 |
| Janssen Research & Development, LLC | $840.00 | 1 |
| Merck Sharp & Dohme Corporation | $787.07 | 8 |
| Janssen Biotech, Inc. | $580.10 | 11 |
| Axonics Modulation Technologies, Inc. | $158.65 | 6 |
| Dendreon Pharmaceuticals LLC | $113.65 | 2 |
| Sumitomo Pharma America, Inc. | $98.32 | 4 |
| BAXTER HEALTHCARE | $88.93 | 2 |
| ABBVIE INC. | $74.72 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $67.85 | 3 |
| Ferring Pharmaceuticals Inc. | $59.16 | 3 |
| ConvaTec Inc. | $47.73 | 1 |
| Endo USA, Inc. | $47.51 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $40.50 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $40.45 | 2 |
| Endo Pharmaceuticals Inc. | $38.10 | 2 |
| Laborie Medical Technologies Corp. | $36.33 | 1 |
| TOLMAR, INC. | $35.28 | 2 |
| Astellas Pharma US Inc | $32.16 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $23.40 | 1 |
| Tempus AI, Inc | $21.14 | 1 |
| STERIS CORPORATION | $20.58 | 1 |
| COLOPLAST CORP | $19.58 | 1 |
| Medtronic, Inc. | $16.10 | 1 |
| BIOTISSUE HOLDINGS INC. | $14.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (77)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.